BCL2 and hepatocellular carcinoma: Western blotting also confirmed that TRIM44, p-STAT3, BCL2, MMP9, HIF-1α and PIM1 was reduced with lower expression of SPATS2 in HCC-LM3-shSPATS2 xenograft tumors (Figure 3D).